Valeant Files Annual Report, Says in Compliance With Covenants
Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its long-delayed 2015 annual report on Friday, and said it was in compliance with its credit agreement and senior note indentures.